Literature DB >> 6351607

Prognostic factors in lupus nephritis. Contribution of renal histologic data.

H A Austin, L R Muenz, K M Joyce, T A Antonovych, M E Kullick, J H Klippel, J L Decker, J E Balow.   

Abstract

The predictive value of laboratory results and renal histologic data was examined in 102 patients upon entry into prospective, randomized, therapeutic trials of lupus nephritis. Three clinical features at the time of entry into the study were individually associated with increased rates of renal failure: age less than 24 years, male gender, and an elevated serum creatinine level. Subjects with diffuse proliferative or membranoproliferative glomerulonephritis were at a modest but significantly increased risk for the development of end-stage renal disease compared with patients with other classes of lupus nephritis. Semiquantitative scores of histologic features (specified by activity and chronicity indexes) identified subgroups of patients with comparatively high renal failure rates. To address the controversial issue of whether renal histologic data significantly improve the outcome predictions in patients with lupus nephritis, multivariate survival models were generated, permitting simultaneous consideration of multiple prognostic factors. Outcome predictions based on the strongest clinical predictors (age, sex, and serum creatinine level) were significantly enhanced by the addition of activity and chronicity indexes. Only age and chronicity index contributed significantly to the five-variable model and together constituted a two-variable model, the predictions of which were similar to observed outcomes. In the context of the highly significant prognostic indicators (age and chronicity index), immunosuppressive agents appeared to provide a slight therapeutic advantage over oral corticosteroids alone.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6351607     DOI: 10.1016/0002-9343(83)90338-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  150 in total

1.  Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice.

Authors:  Marton Keszei; Yvette E Latchman; Vijay K Vanguri; Daniel R Brown; Cynthia Detre; Massimo Morra; Carolina V Arancibia-Carcamo; Carolina V Arancibia; Elahna Paul; Silvia Calpe; Wilson Castro; Ninghai Wang; Cox Terhorst; Arlene H Sharpe
Journal:  Int Immunol       Date:  2011-01-28       Impact factor: 4.823

2.  Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis.

Authors:  Adnan N Kiani; Tianfu Wu; Hong Fang; Xin J Zhou; Chul W Ahn; Laurence S Magder; Chandra Mohan; Michelle Petri
Journal:  J Rheumatol       Date:  2012-04-15       Impact factor: 4.666

Review 3.  Role of TWEAK in lupus nephritis: a bench-to-bedside review.

Authors:  Jennifer S Michaelson; Nicolas Wisniacki; Linda C Burkly; Chaim Putterman
Journal:  J Autoimmun       Date:  2012-06-22       Impact factor: 7.094

4.  In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis.

Authors:  Anthony Chang; Scott G Henderson; Daniel Brandt; Ni Liu; Riteesha Guttikonda; Christine Hsieh; Natasha Kaverina; Tammy O Utset; Shane M Meehan; Richard J Quigg; Eric Meffre; Marcus R Clark
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

5.  Systemic lupus erythematosus. III. Observations on clinical renal involvement and follow up of renal function: Dutch experience with 110 patients studied prospectively.

Authors:  J C Nossent; W Bronsveld; A J Swaak
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

6.  Evaluation of activity, chronicity and tubulointerstitial indices for childhood lupus nephritis.

Authors:  Michael Zappitelli; Ciarán M Duffy; Chantal Bernard; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2007-10-24       Impact factor: 3.714

7.  Treatment of severe IgA nephropathy in children.

Authors:  S P Andreoli; J M Bergstein
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 8.  The treatment of lupus nephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

9.  Lupus nephritis in Egyptian children: a 16-year experience.

Authors:  Atef Elmougy; Amr Sarhan; Ayman Hammad; Ahmed El-Refaey; Mohammed Zedan; Riham Eid; Wafaa Laimon; Wafaa Limon; Ashraf Abd Elrahman; Fatma Elhussieni; Enas El-Sherbeny; Ashraf Bakr
Journal:  J Nephrol       Date:  2014-12-10       Impact factor: 3.902

10.  Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice.

Authors:  J Quddus; K J Johnson; J Gavalchin; E P Amento; C E Chrisp; R L Yung; B C Richardson
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.